Nuevocor
PrivateLast Round
Series B
May 6, 2025
Total Funding Raised
$69M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nuevocor is a biotechnology company that develops gene therapies for cardiomyopathies driven by aberrant mechanobiology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuevocor Comparables
Compare Nuevocor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affinia Therapeutics | 79% | |
| DiNAQOR AG | 76% | |
| Bayer AG | 74% | |
Nuevocor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 6, 2025 | ||||
| Series A | Jun 18, 2021 |
Key People
Founding team and executive leadership
Nuevocor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xora Innovation | Series B, Series A |
| SEEDS Capital | Series B, Series A |
| Highlight Capital | Series B |
| ClavystBio | Series B |
| EDBI | Series B, Series A |
| Angelini Ventures | Series B |
| EVX Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
First-in-human study of NVC-001 for LMNA-associated DCM to begin.
- Apr 28, 2026
Dr. Shah appointed to lead global clinical development and medical affairs.
Nuevocor Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuevocor's valuation, stock price, and market status.